good point. $3 billion in cash and they feel they have to eliminate a dividend that costs them $218 million per year. that does reek of desperation. maybe management really doesn't know what they are doing. btw-- i'm long at $13.
exactly--- which is why the stock should not be down this much. i call the bottom tomorrow. RIG not going any lower after tomorrow.
I didn't say anything about "safe". Purely relative price action-- which, given that HK is a more speculative play-- held up great relative to a lot of stocks during the meltdown. The relative price action suggests that HK will do well from here on out-- IF the market recovers through year-end. If HK were so risky-- then why did HK not move a penny lower since 7/27? HK is a GREAT speculative play. HK could be up 50% in a couple of weeks time.
Bears will laugh-- BUT HK close 7/27: 87 cents. Today's price: 87 cents. S&P 500 close 7/27? 2067.64. Overall market down almost 6.5% since 7/26-- and HK flat. I'll take that.
OK thanks-- I see it now. However that doesn't change the fact that they invested $75 million at $15/sh. And agreed to a lockup even though it's only 90 days as you say. At $20, it's 10% position for RA (as/of 6/30) and at $10 it's still a top 5 position. As you say, who knows what they do post-lockup.
So you're saying that because RA is a 5% holder on the IPO that they are subject to lock-up restrictions? If they were so uncertain, then why didn't they just buy 4.9% of the company? Or were they involved earlier-- pre-IPO?
check out 13F just filed for June 30. News should help keep a floor under FTR. Small position for Baupost at only 1.1%.
look fool. i don't crow about my investments, i just state facts. 1- i own 55,000 ACHN at 2.50 cost. 2- RA Capital is the best biotech investor over the last decade. i understand that you can't debate the first point-- but please educate me on who you think is a better biotech investor over the last decade. i never said that RA has a 100% batting average-- Who TF in biotech ever has one?? as I said-- get a clue.
obviously your reading comprehension isn't so good. i said I HAVE NO POSITION in AXON, but do follow the best biotech investor over the last decade-- that being RA Capital. AXON worth a serious look. but no, I should take dementia's advice. LMFAO.
you're clearly an idiot. RA bought 22 million shares of ACHN in the 2's-- when I bought 55,000. They took profits when the stock was double-digits and are now buying back in. RA happens to be the best biotech investor over the last decade. you think anyone else is better? get a clue.
If you don't know about RA, then just look them up. The best biotech investor over the last decade. I don't own any AXON, but will look to own soon. RA just filed their 13F for June 30.